NCT00712634View on ClinicalTrials.gov

Cytomegalovirus Vaccine in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 30, 1997

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Precancerous/Nonmalignant Condition
Interventions
BIOLOGICAL

CMVpp65-A*0201 peptide vaccine

Vaccine received on either days 0 and 28 or on days 0, 28, and 56 and perhaps day 90

Trial Locations (1)

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00712634 - Cytomegalovirus Vaccine in Healthy Participants | Biotech Hunter | Biotech Hunter